This consultation closed on 24 February 2021
The APVMA is considering an application for approval of the new active constituent fomesafen and registration of the product Reflex Herbicide, containing 240 g/L fomesafen, as a soluble concentrate formulation. The product is intended for the control of a range of broadleaf weeds when applied prior to sowing or post-sowing, pre-emergence in chickpeas, lupins, lentils, field peas, faba beans and vetch.
We invite comment from 27 January 2021 to 24 February 2021 on whether approval of the active constituent and registration of the product should be granted.
The APVMA is able to consider comments relating to the legislative grounds, including:
- occupational health and safety
- public health
- chemistry and manufacture
- residues in food
- environmental safety
- trade
- efficacy and target crop safety
Download the Public Release Summary on the evaluation of Reflex Herbicide.
For more information see page 26, APVMA Gazette No 2. 27 January 2021.
Please note: Submissions will be published on the APVMA’s website, unless you have asked for the submission to remain confidential (see public submission coversheet).
Please lodge your submission with a public submission coversheet, which provides options for how your submission will be published.
Note that all APVMA documents are subject to the access provisions of the Freedom of Information Act 1982 and may be required to be released under that Act should a request for access be made.
Please send your written submission and coversheet by email or post to:
Email: enquiries@apvma.gov.au
Post:
Executive Director, Registration Management
Australian Pesticides and Veterinary Medicines Authority
GPO Box 3262
Sydney NSW 2001
Submissions received
The APVMA sought comments from interested stakeholders on the application for approval of the new active constituent fomesafen and registration of the product Reflex Herbicide, in a consultation that closed on 24 February 2021.
A total of 2 submissions were received from industry bodies.
A copy of the published submissions is available on our website.
Consultation feedback
We have completed our review of the submission and finalised registration of the product.